President and Chief Executive Officer
Mr. Michels has been the Company’s President and Chief Executive Officer and has been a member of the Board since June 2004. Prior to that, Mr. Michels served as Group Vice President, Global Marketing of Ortho-Clinical Diagnostics, President of Ortho-Clinical Diagnostics International, and President of Johnson & Johnson Healthcare Systems, Inc. Earlier in his career, Mr. Michels held various sales and marketing positions of increasing responsibility within the Johnson & Johnson family of companies and with the Diagnostics Division of Abbott Laboratories. Mr. Michels received a B.S. degree in Public Health Administration from the University of Illinois and an M.B.A. from Rutgers University. Mr. Michels recently served on the Presidential Advisory Council on HIV/AIDS (PACHA) and currently serves on the boards of directors of West Pharmaceutical Services, Inc. and the Miller Keystone Blood Center.
Chief Operating Officer and Chief Financial Officer
Mr. Spair has been the Company’s Chief Financial Officer and Chief Operating Officer and has been a member of the Board since September 2006. He served as Executive Vice President and Chief Financial Officer of the Company since November 2001. Prior to that time, Mr. Spair served as Chief Financial Officer for various companies in the pharmaceutical industry, including Delsys Pharmaceutical Corporation, SuperGen, Inc., Sparta Pharmaceuticals, Inc. and Envirogen, Inc. Mr. Spair received both his B.S. degree in Accounting and M.B.A. from Rider College. He is also a licensed Certified Public Accountant, a Chartered Global Management Accountant, a member of the New Jersey Society of Certified Public Accountants and the American Institute of Certified Public Accountants. He serves on the boards of Fulton Financial Corporation and Life Sciences PA.
Executive Vice President, Business Unit Leader, Infectious Disease
Tony Zezzo has been the Executive Vice President, Business Unit Leader, Infectious Disease since January 2017, and prior to that served as Executive Vice President, Marketing and Sales since January 2011. Prior to joining OraSure, Mr. Zezzo was Vice President, North America Sales and Marketing at the Ortho-Clinical Diagnostics division of Johnson & Johnson. Mr. Zezzo also held a series of sales and marketing positions of increasing responsibility within Johnson & Johnson. Mr. Zezzo received a B.A. degree in Political Science from Grove City College.
Senior Vice President, General Counsel and Secretary
Jack E. Jerrett has been the Company’s Senior Vice President and General Counsel since February 2003 and served as the Vice President and General Counsel since November 2000. He has also served as the Company’s Secretary since February 2001. Prior to joining the Company, Mr. Jerrett worked as an Associate at Morgan, Lewis & Bockius and held positions of increasing legal responsibilities with companies in the transportation and energy industries. Mr. Jerrett received a B.S. degree in Accounting from Villanova University and a Juris Doctor from the Villanova University School of Law. He is a member of the Pennsylvania Bar and the American and Pennsylvania Bar Associations.
Senior Vice President, Finance, Controller and Assistant Secretary
Mark L. Kuna has been the Company's Senior Vice President, Finance and Controller since September 2006, and served as Vice President and Controller since February 2003 and as Controller since February 2001. Mr. Kuna has also served as the Company's Assistant Secretary since May 2002 and provided accounting and financial analysis support since joining the Company in October 2000. Prior to that time, Mr. Kuna served as an accountant with Deloitte and Touche and held senior accounting and management positions with companies in the petrochemical, manufacturing, and telecommunications industries. Mr. Kuna received a B.S. degree in Accounting from the University of Scranton, and is a licensed Certified Public Accountant, a Chartered Global Management Accountant and a member of the Pennsylvania and American Institutes of Certified Public Accountants.
Senior Vice President, Operations
Nancy McLane has been the Senior Vice President, Operations since December 2009. Prior to joining OraSure, Ms. McLane was Senior Vice President of Operations at Lifesync Corporation where she had responsibility for operations, quality assurance, regulatory affairs, and global supply chain and customer service for a medical device start-up that specializes in wireless electrocardiogram systems. Prior to that, she served as Executive Director of Operations at Cordis Corporation, a Johnson & Johnson company, where she had roles in operations management and new product development support. Prior to her work at Johnson & Johnson, Ms. McLane spent thirteen years at C.R. Bard, a multi-national producer and distributor of medical devices, where she held roles as Plant Manager at facilities in the U.S. and Mexico. Ms. McLane received a B.S. degree in Civil Engineering from Worcester Polytechnic Institute, an M.S. degree in Environmental Engineering from Northeastern University and an M.B.A. from Bentley College.
Senior Vice President, Research and Development and Chief Science Officer
Michael Reed, Ph.D. has been the Senior Vice President of Research and Development and Chief Science Officer since April 2016. Prior to joining the Company, Dr. Reed spent eight years at Beckman Coulter, a global diagnostics and life sciences company within the Danaher Corporation, serving in a variety of leadership positions, including Director of Global Assay and Applications Development for the Beckman Coulter Life Science business and Director of Scientific Affairs for the Cellular Analysis Business Group. Under his leadership, Beckman Coulter launched and commercialized over 300 products globally across multiple disciplines. Prior to his work at Beckman Coulter, Dr. Reed served as Director of Product Development with Osmetech Molecular Diagnostics where he led the effort to develop two U.S. FDA 510(K) cleared IVD systems for cystic fibrosis genotyping and a pharmacogenetics test to guide warfarin dosing. Dr. Reed received a Ph.D. in Biochemistry from the University of Adelaide (Australia) and a BSc. degree in Biochemistry from The Australian National University (Canberra, Australia). He also conducted post-doctoral research at the Beckman Research Institute at the City of Hope in Duarte, California.
Senior Vice President, Business Unit leader, Molecular Solutions
Brian Smith has been the Senior Vice President, Business Unit leader, Molecular Solutions with the Company’s subsidiary, DNA Genotek, Inc., since January 2017, and prior to that served as DNA Genotek’s Vice President of Sales since January 2008. Prior to joining DNA Genotek, Mr. Smith was Director of Sales and Marketing for Telephonetics VIP plc, a UK speech recognition company. Previous positions include Vice President of Marketing at Cloakware Corporation (Ottawa), President of Ponte Communications (California), and executive positions at Entrust Technologies in both North America and Europe. Mr. Smith has a Bachelor of Commerce degree from McGill University with a major in Management Information Systems.
Senior Vice President, Business Development
Jill Thompson joined OraSure Technologies in 2012 as Senior Vice President, Business Development.
Ms. Thompson brings to OraSure extensive business development, sales and marketing expertise, most recently as Vice President of Licensing & Business Development for Alere, Inc. (formerly Inverness Medical Innovations), where she drove acquisitions and licensing agreements for new medical technologies and products focused on diagnosing disease, including extensive contractual, legal, and patent work. During her extensive tenure at Alere, she also held roles as Director of Sales and Marketing for Drugs of Abuse and International Sales Manager for Rapid Diagnostics.
Prior to Alere, Ms. Thompson was with Bristol-Myers Squibb, where she marketed products for the Neuroscience Infectious Disease Division. On the sales side, Ms. Thompson represented Astra Pharmaceuticals where she was involved in the marketing of the blockbuster drug Prilosec.
Ms. Thompson received a B.S. in Psychology from Texas A&M University.
Senior Vice President and General Manager, Consumer Products
Kathleen Weber has been the Senior Vice President and General Manager, Consumer Products since November 2012. Prior to joining OraSure, Ms. Weber held several senior leadership positions in marketing, sales and Rx-to-OTC switch at Pfizer Consumer HealthCare, Johnson and Johnson Consumer HealthCare and Schering–Plough Healthcare. She has managed categories ranging from pain management, respiratory care, feminine hygiene, skin care and oral care, leading iconic brands such as Listerine, Claritin, Neosporin, Dr. Scholl’s, Stayfree and Carefree. Ms. Weber began her career in the financial services industry and held various positions in U.S. and global marketing and operations at Chase Manhattan Bank. Ms. Weber received a B.S. degree in business administration from Georgetown University and earned an M.B.A. from New York University’s Stern School of Business.
|Print Page | E-mail Page | RSS Feeds | E-mail Alerts | IR Contacts | Financial Tear Sheet|